Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty analysts that are covering the firm, MarketBeat reports. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year price objective among […]
Evercore ISI Lowers Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $210.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY) Shares Gap Down After Analyst Downgrade theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lowered by equities research analysts at Morgan Stanley from $210.00 to $175.00 in a note issued to investors on Monday, FlyOnTheWall reports. Morgan Stanley’s target price would suggest a potential upside of 3.97% from the stock’s previous close. ALNY has been the subject of […]
Equities researchers at Raymond James assumed coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) in a research report issued on Thursday, FlyOnTheWall reports. The brokerage set an “outperform” rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the stock. Sanford C. Bernstein cut their target […]